ACS Medicinal Chemistry Letters

Papers
(The median citation count of ACS Medicinal Chemistry Letters is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Cancer-Cell-Selective Targeting by Arylcyclopropylamine–Vorinostat Conjugates96
Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate Cancer95
Design and Characterization of 1,3-Dihydro-2H-benzo[d]azepin-2-ones as Rule-of-5 Compliant Bivalent BET Inhibitors88
Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport56
Azapodophyllotoxin Causes Lymphoma and Kidney Cancer Regression by Disrupting Tubulin and Monoglycerols50
Psychiatric Treatments with Short-Duration Psychedelics and AI-Driven Behavioral Monitoring48
Clozapine as an E3 Ligand for PROTAC Technology48
From Virtual Screens to Cellular Target Engagement: New Small Molecule Ligands for the Immune Checkpoint LAG-346
Discovery of Orally Bioavailable FGFR2/FGFR3 Dual Inhibitors via Structure-Guided Scaffold Repurposing Approach43
Conformationally Restricted Analogues of α-Galactosylceramide as Adjuvant in COVID-19 Subunit Vaccine43
Macrocyclic Oxindole Peptide Epoxyketones─A Comparative Study of Macrocyclic Inhibitors of the 20S Proteasome41
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors38
Application of Deuterated N,N-Dimethyltryptamine in the Potential Treatment of Psychiatric and Neurological Disorders38
Synthesis of Monofluorinated 7-Hydroxycoumarin-3-Carboxamides as Cell-Permeable Fluorescent Molecular Probes37
Introducing the Potential Binding Interface between the TRAIL-Mimicking Peptide and DR5 via Alanine Scan35
Novel Heterocyclic Pyrimidine Derivatives as GSK3α Inhibitors34
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology34
Novel Tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine Compounds as Oxytocin Receptor Agonists for Treating Autism Spectrum Disorders33
Targeting the “Undruggable” Driver Protein, KRASG12D, as Potential Therapy in Prostate Cancer32
Call for Papers: Fungal Pathogens – Life Cycle, Infection, Host Immunity and Drug Discovery32
In This Issue, Volume 14, Issue 532
Novel Phosphorylpurinone Compounds for Treating Cancer29
Correction to “Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay”29
Substituted 2,3-Benzodiazepines Derivatives as Bromodomain BRD4 Inhibitors29
Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second-Generation28
Contemporary Computational Applications and Tools in Drug Discovery28
Emerging Techniques in Cancer Therapy: Precision Targeting for Improved Outcomes28
Discovery of Selective Inhibitors of NaV1.7 Templated on Saxitoxin as Therapeutics for Pain28
Issue Editorial Masthead27
Discovery of a Novel sp3-Rich M1 Positive Allosteric Modulators (PAMs) Chemotype via Scaffold Hopping27
Issue Publication Information27
Methyl and Fluorine Effects in Novel Orally Bioavailable Keap1–Nrf2 PPI Inhibitor26
Issue Publication Information26
Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation26
Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential25
Structure–Activity Relationship and In Silico Evaluation of cis- and trans-PCPA-Derived Inhibitors of LSD1 and LSD225
Targeting Cancer: A New Era in Cancer Therapy through Immune Fitness Modulation and KRAS Degradation25
Evaluating the Diversity and Target Addressability of DELs using Scaffold Analysis and Machine Learning24
Novel Triazines as NLRP3 Inhibitors for Treating Multiple Diseases24
Novel 3-Cycloaminoindole Compounds as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders24
Identification of an Allene Warhead That Selectively Targets a Histidine Residue in the Escherichia coli Oxidoreductase Enzyme DsbA23
An Estrogen Receptor β Agonist with AR Antagonist Activity from a Modern Asymmetric De Novo Steroid Synthesis23
ACS Medicinal Chemistry Letters Patent Highlights: A Look Back23
Quantum Mechanics-Based Ranking of Predicted Proteolysis Targeting Chimeras-Mediated Ternary Complexes22
Novel Compounds as 5-HT2A Receptor Modulators for Treating Psychiatric and Neurological Disorders22
Discovery and Characterization of a Chemical Probe for Cyclin-Dependent Kinase-Like 222
Targeting Oncogenic Pathways: Advances in KRAS, CDK, EGFR, and PROTAC-Based Therapies22
Constructive On-DNA Abramov Reaction and Pudovik Reaction for DEL Synthesis22
Novel Piperidinylpyridinylcarbonitrile Derivatives as QPCT and QPCTL Inhibitors for Treating Cancer22
(−)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase21
Heparan Sulfate-Mimicking Glycopolymers Bind SARS-CoV-2 Spike Protein in a Length- and Sulfation Pattern-Dependent Manner21
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 Agonists21
Piperazinobenzodiazepinones: New Encephalitic Alphavirus Inhibitors via Ring Expansion of 2-Dichloromethylquinazolinones21
N-Arylsulfonylated C-Homoaporphines as a New Class of Antiplatelet and Antimicrobial Agents20
Discovery of N-(4-(Aminomethyl)phenyl)-5-methylpyrimidin-2-amine Derivatives as Potent and Selective JAK2 Inhibitors20
In-Silico Screening-Based Discovery of New Natural eEF2K Inhibitors with Neuritogenic Activity20
3AcFNP-59 for Positron Emission Tomography Imaging of Cholesterol Trafficking and Utilization20
SAR Study of 4,8-Disubstituted Pyrimido[5,4-d]pyrimidines Exhibiting Antitrypanosomal and Antileishmanial Activity20
Optimized Parenteral and Intranasal Formulations of Tryptamine Psychedelics for Rapid-Acting Antidepressant Therapy19
Synthesis and Evaluation of Halogenated Pralidoximes in Reactivation of Organophosphate-Inhibited Cholinesterases19
Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers18
Synthesis and Preclinical Evaluation of Novel 68Ga-DOTA-RBB as Potential PET Radiotracer for Imaging CDK4/6 in Tumors18
Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPD18
Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and Psychoplastogens18
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson’s Disease17
Announcing the Early Career Board of ACS Medicinal Chemistry Letters17
Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in Particular Coronavirus Infections17
Thermal Degradation Kinetics and pH–Rate Profile of Verbascoside and Stability Improvement by Solid Lipid Nanoparticles17
Machine Learning ADME Models in Practice: Four Guidelines from a Successful Lead Optimization Case Study17
Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule CD4-Mimics17
An Automated Purification Workflow Coupled with Material-Sparing High-Throughput 1H NMR for Parallel Medicinal Chemistry17
In Retrospect: Root-Cause Analysis of Structure–Activity Relationships in IRAK4 Inhibitor Zimlovisertib (PF-06650833)16
Interleukin-17A Peptide Aptamers with an Unexpected Binding Moiety Selected by cDNA Display under Heterogenous Conditions16
Homogeneous Dual-Payload Antibody-Drug Conjugates Produced by Combined Distinct Conjugation Strategies16
Exploiting Solvent Exposed Salt-Bridge Interactions for the Discovery of Potent Inhibitors of SOS1 Using Free-Energy Perturbation Simulations16
Enantioselective Bioreduction of Medicinally Relevant Nitrogen-Heteroaromatic Ketones16
Discovery of Novel MTA-Cooperative PRMT5 Inhibitors with a 2,3-Dihydro-1H-imidazo[1,2-b]pyrazole Scaffold16
Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 216
Fragment-Based Dynamic Combinatorial Chemistry for Identification of Selective α-Glucosidase Inhibitors16
Issue Editorial Masthead16
Advancing New Chemical Modalities into Clinical Studies15
Fragment Ligands of the m6A-RNA Reader YTHDF215
Thermal Stability and Utility of Dienes as Protecting Groups for Acrylamides15
Exploring the Therapeutic Potential of Entheogens in Postoperative Cognitive Decline and Psychological Resilience15
Novel Isoindolinone-Containing PARP Inhibitors: Synthesis and Therapeutic Applications in CNS Cancer Treatment15
Synthesis and In Vitro/In Silico α-Glucosidase Inhibitory Study of Novel Ethanones Containing Naphthalene-Linked 1,2,4-Triazole15
Charting the Chemical Space of Acrylamide-Based Inhibitors of zDHHC2015
The Synergistic Effects of 5-HT2A and TRP Agonism/Antagonism in Reducing Inflammation for Enhanced Mental and Physical Health15
Lead Optimization: Synthesis and Biological Evaluation of PBT-1 Derivatives as Novel Antitumor Agents15
Discovery of Novel Pyrazolopyrimidines as Potent, Selective, and Orally Bioavailable Inhibitors of ALK214
Identification and In Silico Binding Study of a Highly Potent DENV NS2B-NS3 Covalent Inhibitor14
Discovery of Potent and Oral Bioavailable MAT2A Inhibitors for the Treatment of MTAP-Deleted Tumors14
Introducing Conformational Restraints on 25CN-NBOH: A Selective 5-HT2A Receptor Agonist14
Small Molecules Blocking the Assembly of TCAB1 and Telomerase Complexes: Lead Discovery and Biological Activity14
Design, Synthesis, and Biological Activity of l-1′-Homologated Adenosine Derivatives14
Development of BET Inhibitors as Potential Treatments for Cancer: Optimization of Pharmacokinetic Properties14
The BASHY Platform Enables the Assembly of a Fluorescent Bortezomib–GV1001 Conjugate14
Discovery of First-in-Class BAZ2A/B and BAZ2B-Selective Degraders14
Structure–Activity Relationships for the N-Me- Versus N-H-Amide Modification to Macrocyclic ent-Verticilide Antiarrhythmics14
Hybrids of Membrane-Translocating Antimicrobial Peptides Show Enhanced Activity through Membrane Permeabilization14
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke14
Proline Homologation in Melanostatin Neuropeptide: Discovery of Potent Modulators of the Dopamine D2 Receptors14
Lipase-Catalyzed Synthesis and Biological Evaluation of N-Picolineamides as Trypanosoma cruzi Antiproliferative Agents14
Novel Furopyridine and Furopyrimidine Compounds as PI4K Inhibitors for Treating Malaria and Viral Infection14
Indole-Containing Pyrazino[2,1-b]quinazoline-3,6-diones Active against Plasmodium and Trypanosomatids13
Novel Imidazotriazine Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Disorders13
SiRNAs with Neutral Phosphate Triester Hydrocarbon Tails Exhibit Carrier-Free Gene-Silencing Activity13
Issue Publication Information13
In Silico Optimized Stapled Peptides Targeting WASF3 in Breast Cancer13
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable In Vivo Studies: Discovery of TDI-1105513
Issue Publication Information13
Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy13
Ir(III) Complex Dimer Nanoparticles for Photodynamic Therapy13
Targeted Degradation of Androgen Receptor for the Potential Treatment of Prostate Cancer13
Spiro(isobenzofuranazetidine) Compounds for Treating Autoimmune Diseases13
Issue Editorial Masthead13
Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders13
Issue Publication Information13
Photoaffinity Probe Reveals the Potential Target of Harringtonolide for Cancer Cell Migration Inhibition13
Synthesis, Anti-Plasmodial Activities, and Mechanistic Insights of 4-Aminoquinoline-Triazolopyrimidine Hybrids13
In the Quest for Potent and Selective Malic Enzyme 3 Inhibitors for the Treatment of Pancreatic Ductal Adenocarcinoma13
2-Aminoimidazole-benzimidazole Conjugates Potentiate the Gram-Positive Selective Antibiotic Clarithromycin against Acinetobacter baumannii13
Re-evaluation of Cyclic Peptide Binding to Neurotensin Receptor 1 by Shifting the Peptide Register during Synthesis13
Issue Editorial Masthead13
Issue Publication Information13
Synthesis and Evaluation of Novel meso-Tetraphenyltetrabenzoporphyrins for Photodynamic Therapy12
Identification of Boc2Lys-Linked Ethacrynic Acid and Its Analogues As Efficient Glutathione S-Transferase Degraders12
In this Issue, Volume 16, Issue 512
Broad-Spectrum Antimicrobial Efficacy of Cyclic Antimicrobial Peptide Against Multidrug-Resistant Staphylococcus aureus Infections12
Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 Modulators12
Enantiopure Benzofuran-2-carboxamides of 1-Aryltetrahydro-β-carbolines Are Potent Antimalarials In Vitro12
Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones12
Novel Nonpeptide as Oxytocin Receptor Agonist12
Peripherally Restricted Fused Heterocyclic Peptidomimetic Multifunctional Opioid Agonists as Novel, Potent Analgesics12
Synthesis and Evaluation of Benzylamine Inhibitors of Neuropathogenic Naegleria fowleri “Brain-Eating” Amoeba12
Discovery of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors12
Fragment-Based Discovery of Drug-like LRH-1 Agonists12
Design, Synthesis, and Evaluation of 8-(o-Tolyl)quinazoline Derivatives as Small-Molecule PD-1/PD-L1 Antagonists12
Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators12
Synthesis of Benzoazepine Derivatives via Azide Rearrangement and Evaluation of Their Antianxiety Activities11
Bioisostere Effects on the EPSA of Common Permeability-Limiting Groups11
In This Issue, Volume 13, Issue 111
Recent Developments in Mass Spectrometry to Support Next-Generation Synthesis and Screening11
Novel Pyridazin-3(2H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer Activity11
Inhibitors of the Cyclic GMP-AMP Synthase (cGAS) as Potential Treatment for Autoimmune and Inflammatory Diseases11
Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer11
Application of Rapidly Accelerating Fibrosarcoma Protein Degraders in Drug Discovery11
Reducing Self-Assembly by Increasing Net Charge: Effect on Biological Activity of Mastoparan C11
N-Biphenyl Pyrrolinones and Dibenzofurans as RNA-Binding Protein LIN28 Inhibitors Disrupting the LIN28–Let-7 Interaction11
Tetrazole Derivatives as TRPA1 Inhibitors for Treating Idiopathic Lung Disease or Cough11
Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR7 Allosteric Agonist11
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field11
2-Imidazole as a Substitute for the Electrophilic Group Gives Highly Potent Prolyl Oligopeptidase Inhibitors11
Novel Compounds as 5-HT2A Agonists for Treating Mental Illness or CNS Disorders11
Novel Substituted Pyrazoles as 5-HT1A Agonists for Treating Neuropsychiatric Diseases11
Innovative Psychedelic Therapies: Harnessing 5-MeO-DMT and DMT for Mental Health Treatment11
Pyrroloquinolone-Based Compounds as a Novel Antimycobacterial Chemotype11
Amino-cyclohexane Carboxylic Acid Inhibitors of Arginase11
Property-Based Optimization of Cereblon-Based Molecular Glue Degraders11
Discovery of Dolastatinol: A Synthetic Analog of Dolastatin 10 and Low Nanomolar Inhibitor of Tubulin Polymerization11
A Neutral Flavin–Triphenylamine Probe for Mitochondrial Bioimaging under Different Microenvironments10
Correction to “Study of Chalcogen Aspirin Derivatives with Carbonic Anhydrase Inhibitory Properties for Treating Inflammatory Pain”10
Relevance of the Trillion-Sized Chemical Space “eXplore” as a Source for Drug Discovery10
Decarboxylative Cross-Coupling: A Radical Tool in Medicinal Chemistry10
Issue Publication Information10
Structure–Activity Relationship Study of 1H-Pyrrole-3-carbonitrile Derivatives as STING Receptor Agonists10
Discovery of Non-Covalent Inhibitors for SARS-CoV-2 PLpro: Integrating Virtual Screening, Synthesis, and Experimental Validation10
4-Oxo-β-lactams as Covalent Inhibitors of the Mitochondrial Intramembrane Protease PARL10
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors10
Issue Publication Information10
Development of Potent 3-Br-isoxazoline-Based Antimalarial and Antileishmanial Compounds10
Steroid–Quinoline Hybrids for Disruption and Reversion of Protein Aggregation Processes10
Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFRT790M/C797S Mutants10
Novel N-Substituted Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders10
Targeted Degradation of Histone Deacetylases via Bypassing E3 Ligase Targeting Chimeras (BYETACs)10
Synthesis and Determination of Anticancer Activity of Dicobalt Hexacarbonyl 2′-Deoxy-5-alkynylfuropyrimidines10
Selective Wee1 Inhibitors Led to Antitumor Activity In Vitro and Correlated with Myelosuppression10
Issue Publication Information10
Discovery of INCB126503 as a Potent and Selective FGFR2/3 Inhibitor10
9,10-Bis[(4-(2-hydroxyethyl)piperazine-1-yl)prop2-yne-1-yl]anthracene: G-Quadruplex Selectivity and Anticancer Activity10
Beyond 20 in the 21st Century: Prospects and Challenges of Non-canonical Amino Acids in Peptide Drug Discovery10
Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design10
Issue Publication Information10
Issue Editorial Masthead10
Potentiometric Determination of Acid Dissociation Constants (pKa) for an Anticancer Pyrrole-Imidazole Polyamide10
Discovery of a Novel Photocaged PI3K Inhibitor Capable of Real-Time Reporting of Drug Release10
Issue Editorial Masthead10
Pioneering Changes in Psychiatry: Biomarkers, Psychedelics, and AI9
Design, Construction, and Screening of Diversified Pyrimidine-Focused DNA-Encoded Libraries9
How a Blockchain Approach Can Improve Data Reliability in the COVID-19 Pandemic9
In This Issue, Volume 12, Issue 119
Targeting KRAS Mutant Protein Inhibitor for Potential Treatment in Cancer9
Potent, Selective, and Orally Bioavailable Quinazoline-Based STK17A/B Dual Inhibitors9
Novel Piperidine Substituted Pyrazolopyrimidine Derivatives as SGK1 Inhibitors for Treating Cardiovascular Diseases9
Discovery of Indole-Based PDE5 Inhibitors: Synthesis and Pharmacological Evaluation9
Development of BODIPY FL SNS 032 as a Versatile Probe for Constitutive Androstane Receptor and Multiple Kinases9
Biological Effects of Modifications of the Englerin A Glycolate9
Discovery of Selective Aldehyde Dehydrogenase Inhibitors for the Treatment of Cancer9
Mining Druggable Sites in Influenza A Hemagglutinin: Binding of the Pinanamine-Based Inhibitor M0909
Inhibitors of Nav1.7 for the Treatment of Pain9
Modulation of KRAS Mutant by Inhibiting PLK1 Kinase in Cancer Therapeutics9
Novel Aminocyclobutanes as Monoacylglycerol Lipase Modulators9
Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate Approach9
Novel Compounds as NLRP3 Inhibitors for Treating Asthma or COPD9
NMR-Based Fragment Screen of the von Hippel-Lindau Elongin C&B Complex9
MALT1 Inhibitors for Treating Cancer and Immunological Diseases9
Novel Lactams as Cbl-b Inhibitors for Treating Cancer9
Recent Discovery of PARP7 Inhibitors as Anticancer Agents9
ACS Medicinal Chemistry Letters: An Innovation Ten Years in the Making9
Identification, Synthesis, and Characterization of a Major Circulating Human Metabolite of TRPV4 Antagonist GSK27987459
Intramolecular Ring-Opening Decomposition of Aryl Azetidines9
Novel 2-Pyrrolidone Derivatives as Negative Allosteric Modulators of GluN2B-Containing NMDA Receptors9
A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir9
Novel Pyridine Derivatives as 5-HT2A Agonists for Treating Psychiatric Disorders9
The Inhibitors of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT-1) Protease as Potential Treatment of ABC-DLBCL and Similar Diseases9
Novel Macrocyclic Antagonists of the CGRP Receptor Part 2: Stereochemical Inversion Induces an Unprecedented Binding Mode8
Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity8
Synthesis of Marine-Inspired Multifaceted DNA Damaging Spirooxindoles Combating NSCLC and Associated Bacterial Infection8
Issue Publication Information8
Innovations in Precision Oncology: Biomarker-Driven Approaches for Enhanced Cancer Therapy8
Total Synthesis as Training for Medicinal Chemistry8
Novel AHR Agonists for Treating Psoriasis8
DNA-Encoded Macrocyclic Peptide Libraries Enable the Discovery of a Neutral MDM2–p53 Inhibitor8
Structural Evaluations of a Selective Human STINGA230 Agonist and Its Use in Macrophage Immunotherapies8
Discovery of Benzylpiperazine Derivatives as CNS-Penetrant and Selective Histone Deacetylase 6 Inhibitors8
Discovery of Novel Pyrimidine Derivatives as Human Pin1 Covalent Inhibitors8
Integrating Neuroprotective and Anti-inflammatory Strategies in the Development of PI3K Inhibitors for Enhanced Cancer Therapy8
Application of Compositions Comprising a KRAS G12C Inhibitor and an EGFR Inhibitor for the Potential Treatment of Cancer8
Malaria Box-Inspired Discovery of N-Aminoalkyl-β-carboline-3-carboxamides, a Novel Orally Active Class of Antimalarials8
Synthesis and Antifungal Evaluation of New Azole Derivatives against Candida albicans8
Insight on Some Newly Synthesized Trisubstituted Imidazolinones as VEGFR-2 Inhibitors8
Call for Papers: Exploring the Use of AI/ML Technologies in Medicinal Chemistry and Drug Discovery8
In This Issue, Volume 15, Issue 48
Inhibitors of Interleukin 4 Induced Protein 1 (IL4I1) as Potential Treatment for Cancer8
Integrated Advancements in Neuroplasticity, Psychedelic Therapeutics, and AI-Driven Innovations for Precision Medicine8
Identification of 5-Thiocyanatothiazol-2-amines Disrupting WDR5-MYC Protein–Protein Interactions8
Addition to “The Death of the Strategy of Classical Chiral Switches Is an Exaggeration”8
Exploring the 1-(4-Nitrophenyl)-3-arylprop-2-en-1-one Scaffold for the Selective Inhibition of Monoamine Oxidase B8
Ligand Design with Accelerated Disulfide Formation with Serum Albumin to Extend Blood Retention8
Issue Editorial Masthead8
Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists8
Structure–Activity Relationship of Anti-Mycobacterium abscessus Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase Inhibitors8
A Tiny Pocket Packs a Punch: Leveraging Pyridones for the Discovery of CNS-Penetrant Aza-indazole IRAK4 Inhibitors8
Novel Thienopyrrole Compounds for Treating Autoimmune Diseases and Inflammatory Conditions8
Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol8
Allostery Illuminated: Harnessing AI and Machine Learning for Drug Discovery8
Bicyclic Inhibitors of Branched-Chain α-Keto Acid Dehydrogenase Kinase (BDK) with In Vivo Activity8
Investigation of Isobactin Analogues of Teixobactin8
Novel 6-Substituted-3-Phenylisoindolin-1-ones as Cbl-B Inhibitors for Treating Cancer8
Design and Assessment of First-Generation Heterobifunctional PPARα/STING Modulators8
0.069039106369019